Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.06.021
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Pilot Pharmacologic Biomarker Study of Busulfan and Fludarabine in Hematopoietic Cell Transplant Recipients

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2011English

Drug Resistant CMV in Pediatric Hematopoietic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2015English

Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant Recipients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

The Time Is Now: Model-Based Dosing to Optimize Drug Therapy

International Journal of Pharmacokinetics
2017English

Vaccination of Hematopoietic Cell Transplant Recipients

Bone Marrow Transplantation
TransplantationHematology
2009English

Population Pharmacokinetics of Busulfan in Pediatric and Young Adult Patients Undergoing Hematopoietic Cell Transplant

Therapeutic Drug Monitoring
Pharmacology
2015English

Test Dose Pharmacokinetics to Predict Melphalan Dosing in Children Undergoing Hematopoietic Stem Cell Transplant (HSCT) With Organ Impairment☆

Biology of Blood and Marrow Transplantation
TransplantationHematology
2017English

Impact of Adenoviral Stool Load on Adenoviremia in Pediatric Hematopoietic Stem Cell Transplant Recipients

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2015English

Monocyte-Predominant Engraftment, Cytokine Levels and Early Transplant-Related Complications in Pediatric Hematopoietic Stem Cell Recipients

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy